What is ProteanTecs?
ProteanTecs provides advanced on-chip monitoring and predictive analytics solutions designed to enhance visibility, reliability, and performance optimization across the entire chip lifecycle. By leveraging deep data insights and sophisticated machine learning algorithms, the company empowers the electronics industry to achieve greater efficiency and foresight in chip development and operation. The company's technology is crucial for managing the complexities of modern electronic systems.
How much funding has ProteanTecs raised?
ProteanTecs has raised a total of $191M across 5 funding rounds:
Series A
$10M
Series B
$35M
Series C
$50M
Other Financing Round
$45M
Series D
$51M
Series A (2017): $10M, investors not publicly disclosed
Series B (2019): $35M, investors not publicly disclosed
Series C (2020): $50M supported by Koch, Valor Equity Partners, and Atreides Management
Other Financing Round (2022): $45M featuring Koch Disruptive Technologies, MediaTek, Advantest, and Porsche SE
Series D (2025): $51M backed by Siemens, IAG Capital Partners, and Samsung Catalyst Fund
Key Investors in ProteanTecs
Siemens
Siemens AG is a technology company focused on industry, infrastructure, transport, and healthcare, developing resource-efficient factories, resilient supply chains, and advanced healthcare solutions.
Samsung Catalyst Fund
Samsung Catalyst Fund is an evergreen multi-stage venture capital fund that invests in deep-tech infrastructure and data-enabled platforms, aiming to foster innovation by working closely with entrepreneurs.
Koch
Koch Industries owns a diverse group of companies involved in refining, chemicals, and biofuels; forest and consumer products; fertilizers; polymers and fibers; process and pollution control systems; electronics, software, and data analytics; minerals; glass; automotive components; ranching; commodity trading; and investments.
What's next for ProteanTecs?
With the recent influx of $51M in a major strategic investment, ProteanTecs is poised for accelerated expansion and innovation. This substantial backing, part of its $191M in total capital, suggests a strong market validation and confidence in the company's trajectory. The strategic nature of this financing indicates potential collaborations and market penetration efforts, likely focusing on scaling its advanced analytics solutions to a broader enterprise client base and further solidifying its position in the competitive semiconductor technology landscape.
See full ProteanTecs company page
